Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria

American Journal of Tropical Medicine and Hygiene

Volumn 69, Issue 4, 2003, Pages 366-371

  Hugosson, Elisabeth ^a   Tarimo, Donath ^b   Troye Blomberg, Marita ^c   Montgomery, Scott M ^a   Premji, Zul ^b   Björkman, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; IMMUNOGLOBULIN G; PARACETAMOL; PROTOZOON ANTIBODY; ANALGESIC AGENT; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC RESISTANCE; ANTIBODY PRODUCTION; ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITE PREVALENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; ANIMAL; BLOOD; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; HOSPITALIZATION; IMMUNOLOGY; INFANT; MALARIA FALCIPARUM; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIMALARIALS; BODY TEMPERATURE; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SEVERITY OF ILLNESS INDEX; SULFADOXINE; TREATMENT OUTCOME;

EID: 0642282005     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.69.366     Document Type: Article

References (24)

1. World Health Organisation, 1990. Practical Chemotherapy of Malaria. World Health Organ Tech Rep Ser 805.
2. Sturchler D, Mittelholzer ML, Kerr L, 1993. How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Saf 8: 160-168.
3. Muller O, van Hensbroek MB, Jaffar S, Drakeley C, Okorie C, Joof D, Pinder M, Greenwood B, 1996. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health 1: 124-132.
4. Darlow B, Vrbova H, Gibney S, Jolley D, Stace J, Alpers M, 1982. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum. Am J Trop Med Hyg 31: 1-9.
5. Bojang KA, Schneider G, Forck S, Obaro SK, Jaffar S, Pinder M, Rowley J, Greenwood BM, 1998. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 92: 73-76.
6. Ertel W, Morrison MH, Ayala A, Chaudry IH, 1991. Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 78: 1781-1788.
7. Landewe RB, Miltenburg AM, Breedveld FC, Daha MR, Dijkmans BA, 1992. Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis. J Rheumatol 19: 1353-1357.
8. Picot S, Peyron F, Donadille A, Vuillez JP, Barbe G, Ambroise-Thomas P, 1993. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 80: 127-133.
9. van den Borne BE, Dijkmans BA, de Rooij HH, le Cessie S, Verweij CL, 1997. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol 24: 55-60.
10. Jeong JY, Jue DM, 1997. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol 158: 4901-4907.
11. Karres I, Kremer JP, Dietl I, Steckholzer U, Jochum M, Ertel W, 1998. Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Physiol 274: R1058-R1064.
12. Hugosson E, Bjorkman A, Troye-Blomberg M, 2002. Chloroquine enhances the number of IL-10 producing cells and the expression of B7-2 and ICAM-1 in in vitro-cultured PBMC. Scand J Immunol 55: 399-408.
13. Brandts CH, Ndjave M, Graninger W, Kremsner PG, 1997. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704-709.
14. Lell B, Sovric M, Schmid D, Luckner D, Herbich K, Long HY, Graninger W, Kremsner PG, 2001. Effect of antipyretic drugs in children with malaria. Clin Infect Dis 32: 838-841.
15. Tarimo DS, Minjas JN, Bygbjerg IC, 2002. Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy. Trop Med Int Health 7: 592-598.
16. Perlmann H, Helmby H, Hagstedt M, Carlson J, Larsson PH, Troye-Blomberg M, Perlmann P, 1994. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol 97: 284-292.
17. Ekvall H, Premji Z, Bjorkman A, 1998. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans R Soc Trop Med Hyg 92: 556-560.
18. Ministry of Health T, 2000. Implementation of a new anti-malaria treatment policy in Tanzania: rationale for change and guide to the process of policy implementation, Task Force Report September 1999. Tanzania Health Res Bull 2: 10-13.
19. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC, 1996. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg 90: 179-181.
20. Rombo L, Bjorkman A, Sego E, Ericsson O, 1986. Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, P. ovale or P. malariae. Trans R Soc Trop Med Hyg 80: 763-766.
21. Lell B, Brandts CH, Graninger W, Kremsner PG, 2000. The circadian rhythm of body temperature is preserved during malarial fever. Wien Klin Wochenschr 112: 1014-1015.
22. Ogle W, 1866. On the diurnal variations in the temperature of the human body in health. St. Georgés Hosp Rep 1: 221-245.
23. Conroy RT, Mills JN, 1970. Human circadian rhythms. First edition. London: Churchill.
24. Gyhrs A, Pedersen BK, Bygbjerg I, Henrichsen J, Heron I, Petersen I, Skinhoj P, 1991. The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines. Am J Trop Med Hyg 45: 613-618.